Myth: Its just a peptide, so it must be gentle Peptides can act like strong signals
Your provider at Better Med Spa will discuss what the evidence does and does not support during your consultation so you can make an informed decision
Phase 1b: Multiple Ascending Dose Study (NCT03014609) Study Title: "Safety, Tolerability, PK and PD of Multiple Doses of Cagrilintide in Subjects With Type 2 Diabetes" Status: Completed Phase: Phase 1b Enrollment: 56 participants with T2D Study Period: 2017-2018 Design: Randomized, double-blind, placebo-controlled Duration: 12 weeks Dose Range: 0.3-4.5 mg SC weekly Population: T2D, BMI 25-40, HbA1c 7-10% Key Results: Weight Loss: 6.0 kg (4.5 mg dose) vs
If you experience anaphylaxis or angioedema, the medication should be permanently discontinued and not restarted
Medical plus behavioral: Clinician oversight integrated with the established WW program
This system prioritizes speed and convenience but limits face-to-face contact and individualized guidance
